RHI AG:戦略・SWOT・企業財務分析

◆英語タイトル:RHI AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015681
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:建設・不動産
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

RHI AG – Strategy, SWOT and Corporate Finance Report
Summary

RHI AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

RHI AG (RHI or ‘the group’) is engaged in the production and sale of refractory materials, systems and services. The group produces a range of refractory products, such as bricks, mixes, mortars and functional products. RHI operates in the Americas, Europe, Africa, and Asia. It is headquartered in Vienna, Austria.

Scope

- Detailed information on RHI AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting RHI AG in the form of a SWOT analysis
- An in-depth view of the business model of RHI AG including a breakdown and examination of key business segments
- Intelligence on RHI AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about RHI AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of RHI AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess RHI AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on RHI AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
RHI AG: Company Overview
RHI AG: Overview and Key Facts
RHI AG: Overview
RHI AG: Key Facts
RHI AG: Key Employees
RHI AG: Key Employee Biographies
RHI AG: Major Products and Services
RHI AG: Company History
RHI AG: Management Statement
RHI AG: Locations and Subsidiaries
RHI AG: Company Analysis
RHI AG: Business Description
RHI AG: Corporate Financial Deals Activity
RHI AG: Financial Deals Overview
RHI AG: Targets and Partners
RHI AG: Top Deals 2013 – 2017YTD*
RHI AG: Advisors
RHI AG: Top Financial Advisors
RHI AG: Mergers and Acquisitions
RHI AG: Divestments
RHI AG: Recent Developments
RHI AG: News and Events Summary
RHI AG: Corporate Governance
RHI AG: Financial Performance
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: RHI AG: Key Facts
Table 2: RHI AG: Key Employees
Table 3: RHI AG: Locations and Subsidiaries
Table 4: RHI AG: Deal Activity by Deal Type - Volume (TTM*)
Table 5: RHI AG: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: RHI AG: M&A Average Deal Size - Value (US$m)
Table 7: RHI AG: Targets and Partners
Table 8: RHI AG: Top Deals 2013 - 2017YTD*
Table 9: RHI AG: Financial Advisor Ranking by Value (US$m)
Table 10: RHI AG: M&A Volume and Value Trend (2013 - YTD*2017)
Table 11: RHI AG: M&A Activity by Geography (2013 - YTD*2017)
Table 12: RHI AG: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 13: RHI AG: Divestments by Geography (2013 - YTD*2017)
Table 14: RHI AG: News and Events Summary
Table 15: RHI AG: Corporate Governance
Table 16: RHI AG: Financial Performance

★海外企業調査レポート[RHI AG:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TaiMed Biologics Inc (4147):製薬・医療:M&Aディール及び事業提携情報
    Summary TaiMed Biologics Inc (TMB) is a biotechnology company that provides novel medicines for the prevention and treatment of viral infectious diseases. The company provides pipeline products such as TMB-355, TMB-607 and TMB-571, among others. It offers TMB-355 which is a proprietary humanized ant …
  • Inretail Peru Corp. (INRETC1):企業の財務・戦略的SWOT分析
    Inretail Peru Corp. (INRETC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Argos Therapeutics Inc (ARGS):製薬・医療:M&Aディール及び事業提携情報
    Summary Argos Therapeutics Inc (Argos) is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of infectious diseases and cancer. The company develops a pipeline of products based on its proprietary Arcelis technology platform. Its Arcelis-based immunotherap …
  • C.H. Robinson Worldwide, Inc.:企業の戦略・SWOT・財務分析
    C.H. Robinson Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary C.H. Robinson Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Franklin Resources, Inc.:企業の戦略・SWOT・財務情報
    Franklin Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Franklin Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • NeuroDerm Ltd:医療機器:M&Aディール及び事業提携情報
    Summary NeuroDerm Ltd (NeuroDerm), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a pharmaceutical company that develops of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs. The company’s liquid form …
  • Ace Hardware Corporation:企業の戦略的SWOT分析
    Ace Hardware Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Standard Chartered Plc:企業のM&A・事業提携・投資動向
    Standard Chartered Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Standard Chartered Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Spritzer Bhd:企業の戦略・SWOT・財務情報
    Spritzer Bhd - Strategy, SWOT and Corporate Finance Report Summary Spritzer Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • PT Bank Bukopin Tbk:企業の戦略・SWOT・財務分析
    PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TG Therapeutics Inc (TGTX):製薬・医療:M&Aディール及び事業提携情報
    Summary TG Therapeutics Inc (TG Therapeutics) is a biopharmaceutical company which acquires, develops and commercializes pharmaceutical products for the treatment of B-cell malignancies and autoimmune diseases. The company develops two therapies, namely, TG-1101 (ublituximab) and TGR-1202 for the tr …
  • Mainstream Renewable Power Ltd:企業の戦略的SWOT分析
    Mainstream Renewable Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • BioFactura Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioFactura Inc (Biofactura) is a manufacturer of biosimilars that discovers, develops and markets biodefense drugs and client selected novel drugs. The company provides contract services such as process development, stable cell lines, manufacturing, and others. Its stable cell line offers st …
  • Petroliam Nasional Bhd:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroliam Nasional Bhd (Petronas) is an integrated oil and gas company that explores, develops and produces of oil and natural gas in Malaysia and overseas. It also carries out downstream operations such as processing and liquefaction of natural gas; refining and marketing of petroleum produ …
  • Interventional Spine, Inc.-医療機器分野:企業M&A・提携分析
    Summary Interventional Spine, Inc. (Interventional Spine) is a medical device company, which designs, develops and markets patented systems to treat back pain. The company’s major products include PerX360° percutaneous lumbar fusion system, PERPOS PLS percutaneous transfacet-pedicular compression sy …
  • Airbus SE.:企業の戦略・SWOT・財務分析
    Airbus SE. - Strategy, SWOT and Corporate Finance Report Summary Airbus SE. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Banco Davivienda Sa:企業の戦略・SWOT・財務分析
    Banco Davivienda Sa - Strategy, SWOT and Corporate Finance Report Summary Banco Davivienda Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • GNI Group Ltd (2160):企業の財務・戦略的SWOT分析
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery, an …
  • Livzon Pharmaceutical Group Inc (000513):製薬・医療:M&Aディール及び事業提携情報
    Summary Livzon Pharmaceutical Group Inc (Livzon), a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The company provides preparation drug products, bulk medicines and inte …
  • Electrovaya Inc (EFL):電力:M&Aディール及び事業提携情報
    Summary Electrovaya Inc (Electrovaya), formerly Electrofuel Inc, is an energy storage solutions company that designs, develops, manufactures and markets power technology products. The company’s products include lithium ion super polymer batteries, battery systems, electrodes, cells, modules, separat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆